science pharmaceutical expo biotech jobs

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Makrigiannis, A. P.
Right arrow Articles by Anderson, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Makrigiannis, A. P.
Right arrow Articles by Anderson, S. K.
(Journal of Leukocyte Biology. 2000;68:765-771.)
© 2000 by Society for Leukocyte Biology

Identification of the Ly49L protein: evidence for activating counterparts to inhibitory Ly49 proteins

Andrew P. Makrigiannis*, Jessica Etzler*, Robin Winkler-Pickett*, Anna Mason*, John R. Ortaldo* and Stephen K. Anderson*,{dagger}

* Laboratory of Experimental Immunology, Division of Basic Sciences, and
{dagger} Intramural Research Support Program, SAIC Frederick, National Cancer Institute-FCRDC, Frederick, Maryland

Correspondence: Stephen K. Anderson, SAIC-Frederick, NCI-FCRDC, Bldg. 560, Rm. 31-93, Frederick, MD 21702-1201. E-mail: andersn{at}mail.ncifcrf.gov

Previous studies have indicated that NK cells from different strains of inbred mice may express distinct Ly49 repertoires. Screening of NK cells from the CBA/J mouse for inhibitory and activating Ly49s revealed a novel DAP12-associated receptor that was immunoprecipitated with the Ly49G-specific mAb 4D11. Degenerate primers were designed to amplify and clone Ly49 cDNAs from CBA/J NK cells. A novel activating Ly49 cDNA was identified, which bears strong homology to the partially sequenced Ly49l gene found in C57BL/6 mice. Transfection of Ly49l into a DAP12+ cell line and subsequent immunoprecipitation experiments showed that Ly49L is likely the activating Ly49 detected by the 4D11 antibody in CBA/J NK cells. Antibody-mediated cross-linking of Ly49L induced DAP12 phosphorylation, providing evidence that Ly49L is a functional activating receptor. Comparison of the extracellular domains of Ly49 family members indicates that all known activating members have an inhibitory counterpart with a highly related extracellular region.

Key Words: NK cells • Ly49 • cell surface receptors • signal transduction




This article has been cited by other articles:


Home page
J. Immunol.Home page
O. Zohar, Y. Reiter, J. R. Bennink, A. Lev, S. Cavallaro, S. Paratore, C. G. Pick, G. Brooker, and J. W. Yewdell
Cutting Edge: MHC Class I-Ly49 Interaction Regulates Neuronal Function
J. Immunol., May 15, 2008; 180(10): 6447 - 6451.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Kielczewska, H.-S. Kim, L. L. Lanier, N. Dimasi, and S. M. Vidal
Critical Residues at the Ly49 Natural Killer Receptor's Homodimer Interface Determine Functional Recognition of m157, a Mouse Cytomegalovirus MHC Class I-Like Protein
J. Immunol., January 1, 2007; 178(1): 369 - 377.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Shimizu, J. Koike, H. Wakao, K.-i. Seino, H. Koseki, T. Kakiuchi, T. Nakayama, and M. Taniguchi
Role of a NK receptor, KLRE-1, in bone marrow allograft rejection: analysis with KLRE-1-deficient mice
Blood, August 1, 2004; 104(3): 781 - 783.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. H. Mason, J. Willette-Brown, S. K. Anderson, W. G. Alvord, R. L. Klabansky, H. A. Young, and J. R. Ortaldo
Receptor Glycosylation Regulates Ly-49 Binding to MHC Class I
J. Immunol., October 15, 2003; 171(8): 4235 - 4242.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Raziuddin, D. L. Longo, M. Bennett, R. Winkler-Pickett, J. R. Ortaldo, and W. J. Murphy
Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens
Blood, September 26, 2002; 100(8): 3026 - 3033.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Saleh, A. P. Makrigiannis, D. L. Hodge, and S. K. Anderson
Identification of a Novel Ly49 Promoter That Is Active in Bone Marrow and Fetal Thymus
J. Immunol., May 15, 2002; 168(10): 5163 - 5169.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. P. Makrigiannis, A. T. Pau, A. Saleh, R. Winkler-Pickett, J. R. Ortaldo, and S. K. Anderson
Class I MHC-Binding Characteristics of the 129/J Ly49 Repertoire
J. Immunol., April 15, 2001; 166(8): 5034 - 5043.
[Abstract] [Full Text] [PDF]